Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Publishes 5 PCCP Principles For ML Devices In Collaboration With Canada And UK

Executive Summary

Five guiding principles for PCCPs for ML devices exemplify international harmonization efforts from regulators.

You may also be interested in...

‘We Need To Be Transparent About Our Failures,’ Experts Say About AI Development

 Stakeholders discussed the need for transparency and explainability of AI models at the AI Summit in Cincinnati. 

Global Medtech Guidance Tracker: October 2023

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Forty-five documents have been posted on the tracker since its last update.

AI Development Should Utilize ‘Health Equity By Design’ Principle

Health equity by design should be a core principle of AI/ML development, a national health IT official told the US Congress during Global Health Equity Week.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts